Search research articles
Contact Us
Filters
Showing results (371-380 of 3,661) with videos related to
Page
of 367
Sort By:
Diagnostic Microbiology and Infectious Disease
|
January 1, 1994
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534
R N Jones, M L Sanchez
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1994
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies
H S Sader, R N Jones
Psychopharmacology
|
March 1, 1994
Influence of naloxone upon motor activity induced by psychomotor stimulant drugs
D N Jones, S G Holtzman
Chemotherapy
|
January 1, 1995
Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group
D J Hoban, R N Jones
Journal of the American College of Nutrition
|
January 1, 1983
Nutritional assessment and preliminary report on early support of the trauma patient
E E Moore, T N Jones
Journal of Clinical Microbiology
|
January 1, 1995
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin
M G Cormican, R N Jones
Antimicrobial Agents and Chemotherapy
|
June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations
A L Barry, R N Jones
Diagnostic Microbiology and Infectious Disease
|
May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response
R N Jones, M N Dudley
Diagnostic Microbiology and Infectious Disease
|
May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
February 19, 2013
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)
Ronald N Jones, Matthew G Stilwell
Page
of 367
Search research articles
Search
Showing results (371-380 of 3,661) with videos related to
Sort By:
Page
of 367
Diagnostic Microbiology and Infectious Disease
|
January 1, 1994
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534
R N Jones, M L Sanchez
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1994
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies
H S Sader, R N Jones
Psychopharmacology
|
March 1, 1994
Influence of naloxone upon motor activity induced by psychomotor stimulant drugs
D N Jones, S G Holtzman
Chemotherapy
|
January 1, 1995
Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group
D J Hoban, R N Jones
Journal of the American College of Nutrition
|
January 1, 1983
Nutritional assessment and preliminary report on early support of the trauma patient
E E Moore, T N Jones
Journal of Clinical Microbiology
|
January 1, 1995
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin
M G Cormican, R N Jones
Antimicrobial Agents and Chemotherapy
|
June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations
A L Barry, R N Jones
Diagnostic Microbiology and Infectious Disease
|
May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response
R N Jones, M N Dudley
Diagnostic Microbiology and Infectious Disease
|
May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
February 19, 2013
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)
Ronald N Jones, Matthew G Stilwell
Page
of 367